Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.530
+0.070 (4.79%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Cellectis Employees
As of December 31, 2025, Cellectis had 229 total employees, including 224 full-time and 5 part-time employees. The number of employees increased by 7 or 3.15% compared to the previous year.
Employees
229
Change (1Y)
7
Growth (1Y)
3.15%
Revenue / Employee
$278,703
Profits / Employee
-$285,214
Market Cap
109.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 229 | 7 | 3.15% | 224 | 5 |
| Dec 31, 2024 | 222 | 1 | 0.45% | 216 | 6 |
| Dec 31, 2023 | 221 | -16 | -6.75% | 216 | 5 |
| Dec 31, 2022 | 237 | -63 | -21.00% | 231 | 6 |
| Dec 31, 2021 | 300 | 19 | 6.76% | 294 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 102 |
| Fractyl Health | 100 |
| Oncolytics Biotech | 29 |
| Tenax Therapeutics | 16 |
| Cognition Therapeutics | 14 |
| Tiziana Life Sciences | 10 |
| Atara Biotherapeutics | 10 |
| Coya Therapeutics | 8 |
CLLS News
- 7 hours ago - CLLS Investors Have Opportunity to Join Cellectis S.A. Fraud Investigation with SBS Law - Business Wire
- 2 days ago - CLLS INVESTOR ALERT: Investigation of Cellectis S.A. Announced by Holzer & Holzer, LLC - GlobeNewsWire
- 2 days ago - Securities Fraud Investigation Into Cellectis S.A. (CLLS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Business Wire
- 2 days ago - Cellectis S.A. (CLLS) Shareholders Who Lost Money – Contact Law Offices of Howard G. - Business Wire
- 3 days ago - Securities Fraud Investigation Into Cellectis S.A. (CLLS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. - Business Wire
- 3 days ago - Cellectis downgraded to Underweight from Overweight at Barclays - TheFly
- 4 days ago - Cellectis price target lowered to $8 from $10 at Baird - TheFly
- 4 days ago - Cellectis price target lowered to $3 from $4 at Wells Fargo - TheFly